
AI is about to change healthcare. These 7 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Montage Gold, you need to believe that the company can convert its large Côte d’Ivoire footprint into economic ounces, and then into a producing business, before funding or construction risks bite too hard. The Koné build and its tight cash runway still look like the key near term catalysts and pressure points, but the Wendé update and Dabakala permit subtly shift the story. Confirmation of continuous mineralized trends at Bobosso, on top of 60,000 meters of historic drilling, strengthens the case that Wendé could become a second leg to the thesis rather than a side bet. That said, with no revenue, ongoing losses and a rich price to book, the bigger question is whether the balance sheet can support both construction and aggressive exploration.
However, there is one funding-related risk investors should really have on their radar. Montage Gold's shares are on the way up, but they could be overextended by 7%. Uncover the fair value now.Explore 3 other fair value estimates on Montage Gold - why the stock might be worth 6% less than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Every day counts. These free picks are already gaining attention. See them before the crowd does:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com